Type 1 Diabetes TrialNet
Study Participants Healthcare Professionals Researchers Locations Publications What is TrialNet? News and Events Get Screened! Home
Patient Information

TrialNet has studies for people newly diagnosed with type 1 diabetes. These studies test ways to help people continue to make their own insulin for as long as possible.  New studies are currently being planned.

TrialNet also collaborates with the Immune Tolerance Network, also funded by NIH, to perform studies in this population of individuals.

Learn more about TrialNet studies >